EPIX contrast agent avoids angiography mortalities
This article was originally published in Clinica
Executive Summary
1999 could be a banner year for EPIX Medical. EPIX has developed a new contrast agent that it believes will enable the use of MRI scans to eventually replace X-ray angiography - one of the last major diagnostic tests with a mortality rate.